Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Mar 11, 2026, after the close
10-K filed Mar 11, 2026, 70 days after period end · 0001746473-26-000037
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $1.97M |
| Net Income | -$23.58M |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$49.73M |
| -$41.11M |
| -$35.06M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.